Preferred Stock Investing
Preferred Stock Channel
Market News Video Self Directed Investor The Warren Buffetts Next Door Stock message boards
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Shares Cross 7% Yield Mark
Friday, January 18, 3:06 PM ET, by Market News Video Staff

In trading on Friday, shares of Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) ...

Reminder: Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Goes Ex-Dividend Soon
Tuesday, April 16, 1:55 PM ET, by Market News Video Staff

On 4/17/13, Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) will trade ex-dividend, for ...

Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Shares Cross 8% Yield Mark
Monday, May 6, 2:42 PM ET, by Market News Video Staff

In trading on Monday, shares of Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) ...

Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Shares Cross 10% Yield Mark
Thursday, August 15, 3:15 PM ET, by Market News Video Staff

In trading on Thursday, shares of Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) ...

First Week of November 16th Options Trading For Cyclacel Pharmaceuticals, Inc (CYCC)
Friday, September 27, 12:48 PM ET, by Market News Video Staff

Investors in Cyclacel Pharmaceuticals, Inc (CYCC) saw new options begin trading this week, for the ...

  More articles:  1 2 next »

Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Shares Cross 7% Yield Mark

By Preferred Stock Channel Staff, Friday, January 18, 3:06 PM ET
Play Video: The Importance of Dividends


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (NASDAQ:CYCCP) were yielding above the 7% mark based on its quarterly dividend (annualized to $0.60), with shares changing hands as low as $8.27 on the day. As of last close, CYCCP was trading at a 1.90% discount to its liquidation preference amount. It should be noted that the preferred shares are convertible, with a conversion ratio of 4.2553.

The chart below shows the one year performance of CYCCP shares, versus CYCC:

Performance Comparison Chart

Below is a dividend history chart for CYCCP, showing historical dividend payments on Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock:


Special Offer: Find out what Dave Moenning is holding in the Top 5 Portfolio with a free 30 day trial and a 20% off coupon from Forbes.

In Friday trading, Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (NASDAQ:CYCCP) is currently trading flat on the day, while the common shares (NASDAQ:CYCC) are up about 1.8%.


This Article's Word Cloud:   Below   CYCC   CYCCP   Convertible   Cyclacel   Definition   Dividends   Earnings   Exchangeable   Find   Friday   Nasdaq   Pharmaceuticals   Portfolio   Preferred   Price   Rate   Relative   Start   Stock   Yields   about   above   afterLeftLabels   bkgImage   chart   currently   dividend   escape   fillColor   flat   free   gridBackgroundColor   gridColor   gridLocation   height   labelSide   leftLabelsEvery   movingAverageColors   ratio   shares   showHighsLows   showVolumeTable   showing   slideshow   trading   versus   while   with   year

Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Shares Cross 7% Yield Mark | www.PreferredStockChannel.com | Copyright © 2011 - 2014, All Rights Reserved

Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.